Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer

BACKGROUND: Preclinical and epidemiological studies indicate a potential chemopreventive role of low-density lipoprotein cholesterol (LDL-C) -lowering drugs in the risks of breast cancer and prostate cancer, but the causality remains unclear. We aimed to evaluate the association of genetically proxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lulu, Ding, Huan, Jia, Yiming, Shi, Mengyao, Guo, Daoxia, Yang, Pinni, Wang, Yu, Liu, Fanghua, Zhang, Yonghong, Zhu, Zhengbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840684/
https://www.ncbi.nlm.nih.gov/pubmed/35151363
http://dx.doi.org/10.1186/s13058-022-01508-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840684/
https://www.ncbi.nlm.nih.gov/pubmed/35151363
http://dx.doi.org/10.1186/s13058-022-01508-0

Ejemplares similares